These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16169855

  • 41. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D.
    Rosen DB, Araki M, Hamerman JA, Chen T, Yamamura T, Lanier LL.
    J Immunol; 2004 Aug 15; 173(4):2470-8. PubMed ID: 15294961
    [Abstract] [Full Text] [Related]

  • 42. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.
    Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ.
    J Immunol; 2004 Sep 15; 173(6):3725-31. PubMed ID: 15356118
    [Abstract] [Full Text] [Related]

  • 43. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
    Lee JE, Lim SA, Kim TJ, Kim K, Ng J, Kim YH, Jang IJ, Oh SB, Lee JC, Yee C, Kumar V, Lee KM.
    Eur J Immunol; 2014 Jun 15; 44(6):1802-13. PubMed ID: 24610736
    [Abstract] [Full Text] [Related]

  • 44. Costimulation of multiple NK cell activation receptors by NKG2D.
    Ho EL, Carayannopoulos LN, Poursine-Laurent J, Kinder J, Plougastel B, Smith HR, Yokoyama WM.
    J Immunol; 2002 Oct 01; 169(7):3667-75. PubMed ID: 12244159
    [Abstract] [Full Text] [Related]

  • 45. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.
    Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier LL.
    J Immunol; 2010 Jul 01; 185(1):157-65. PubMed ID: 20530257
    [Abstract] [Full Text] [Related]

  • 46. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
    Vivier E, Tomasello E, Paul P.
    Curr Opin Immunol; 2002 Jun 01; 14(3):306-11. PubMed ID: 11973127
    [Abstract] [Full Text] [Related]

  • 47. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.
    Walsh KB, Lanier LL, Lane TE.
    J Virol; 2008 Mar 01; 82(6):3031-44. PubMed ID: 18160433
    [Abstract] [Full Text] [Related]

  • 48. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL.
    J Exp Med; 2003 May 19; 197(10):1245-53. PubMed ID: 12756263
    [Abstract] [Full Text] [Related]

  • 49. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
    Dhanji S, Teh HS.
    J Immunol; 2003 Oct 01; 171(7):3442-50. PubMed ID: 14500639
    [Abstract] [Full Text] [Related]

  • 50. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 01; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

  • 51. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.
    Coudert JD, Scarpellino L, Gros F, Vivier E, Held W.
    Blood; 2008 Apr 01; 111(7):3571-8. PubMed ID: 18198346
    [Abstract] [Full Text] [Related]

  • 52. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
    Abdool K, Cretney E, Brooks AD, Kelly JM, Swann J, Shanker A, Bere EW, Yokoyama WM, Ortaldo JR, Smyth MJ, Sayers TJ.
    J Immunol; 2006 Aug 15; 177(4):2575-83. PubMed ID: 16888019
    [Abstract] [Full Text] [Related]

  • 53. ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.
    Sutherland CL, Rabinovich B, Chalupny NJ, Brawand P, Miller R, Cosman D.
    Blood; 2006 Aug 15; 108(4):1313-9. PubMed ID: 16621962
    [Abstract] [Full Text] [Related]

  • 54. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
    Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A.
    Blood; 2008 Feb 01; 111(3):1428-36. PubMed ID: 17993609
    [Abstract] [Full Text] [Related]

  • 55. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
    Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T.
    J Immunol; 2003 Apr 15; 170(8):4196-200. PubMed ID: 12682252
    [Abstract] [Full Text] [Related]

  • 56. Requirements for control of B-cell lymphoma by NK cells.
    Brenner CD, King S, Przewoznik M, Wolters I, Adam C, Bornkamm GW, Busch DH, Röcken M, Mocikat R.
    Eur J Immunol; 2010 Feb 15; 40(2):494-504. PubMed ID: 19950185
    [Abstract] [Full Text] [Related]

  • 57. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.
    Nausch N, Florin L, Hartenstein B, Angel P, Schorpp-Kistner M, Cerwenka A.
    J Immunol; 2006 Jan 01; 176(1):7-11. PubMed ID: 16365389
    [Abstract] [Full Text] [Related]

  • 58. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C, Hayashi S, Kveberg L, Niemi EC, Lanier LL, Vaage JT, Ryan JC.
    J Immunol; 2002 Jul 01; 169(1):22-30. PubMed ID: 12077224
    [Abstract] [Full Text] [Related]

  • 59. NKG2D: A versatile player in the immune system.
    Jelenčić V, Lenartić M, Wensveen FM, Polić B.
    Immunol Lett; 2017 Sep 01; 189():48-53. PubMed ID: 28414183
    [Abstract] [Full Text] [Related]

  • 60. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2007 Nov 15; 67(22):11029-36. PubMed ID: 18006849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.